EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proactive risk assessment and nursing risk management in chemotherapy drugs: FMECA methodology results

Gennaro Laus iD, Giuseppe Bertozzi iD, Aldo Di Fazio iD, Federico Ruta iD, Tommaso Cassano iD, Sipontina Rita Zerulo iD

Journal of Healthcare Risk Management · 2026-04 · 45 (4) · 5-13

DOI: 10.1002/jhrm.70021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Healthcare Risk Management, online erschienen am 25.02.2026. Verfasst von Gennaro Laus und 5 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS CROB, Rionero in Vulture, Italy. Hauptthemen laut MEDLINE: Antineoplastic Agents, Risk Management, Medication Errors. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The study aims to proactively analyze the chemotherapy drug management process, focusing on the nursing role: identifying error modes and proposing improvement interventions. A quality improvement project was conducted at an Onco‐Hematological Department, applying a systematic and prospective approach to evaluate the critical phases of the chemotherapy drug process. A risk analysis was conducted using Failure Mode, Effects, and Criticality Analysis (FMECA). A multidisciplinary team of healthcare professionals with experience in the sector mapped the process, identified potential failure modes, calculated the Risk Priority Numbers (RPNs), and implemented corrective actions. The RPNs were re‐evaluated after three months to measure intervention effectiveness. The analysis identified eight error modes, two of which were classified as high risk: contamination (initial RPN 27) and inaccurate dosing (initial RPN 24). After the implementation of improvement actions, such as specific training and formalized double checking, the RPNs were reduced to 4 and 3, respectively, with an improvement greater than 85%. The application of FMECA has allowed for effective identification and mitigation of the main risks associated with chemotherapeutic drug management, contributing to improve patient safety and nurse perceived quality of performance, through a model replicable in other healthcare settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsRisk ManagementMedication ErrorsRisk AssessmentHumansQuality ImprovementPatient SafetyHealthcare Failure Mode and Effect Analysis

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • IRCCS CROB, Rionero in Vulture, Italy.
  • CIS of Legal Medicine of Basilicata, Potenza, Italy.
  • General Direction, ASL BAT, Barletta, Italy.
  • Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
  • University of Foggia, Foggia, Italy.

ORCID-Profile: Gennaro Laus, Giuseppe Bertozzi, Aldo Di Fazio, Federico Ruta, Tommaso Cassano, Sipontina Rita Zerulo

Zitieren

APA

Laus, G., Bertozzi, G., Di Fazio, A., Ruta, F., Cassano, T., & Zerulo, S. R. (2026). Proactive risk assessment and nursing risk management in chemotherapy drugs: FMECA methodology results. Journal of Healthcare Risk Management, 45(4), 5-13. https://doi.org/10.1002/jhrm.70021

Vancouver

Laus G, Bertozzi G, Di Fazio A, Ruta F, Cassano T, Zerulo SR. Proactive risk assessment and nursing risk management in chemotherapy drugs: FMECA methodology results. Journal of Healthcare Risk Management. 2026;45(4):5-13. doi:10.1002/jhrm.70021

BibTeX
@article{Laus2026,
  author = {Laus, Gennaro and Bertozzi, Giuseppe and Di Fazio, Aldo and Ruta, Federico and Cassano, Tommaso and Zerulo, Sipontina Rita},
  title = {Proactive risk assessment and nursing risk management in chemotherapy drugs: FMECA methodology results},
  journal = {Journal of Healthcare Risk Management},
  year = {2026},
  volume = {45},
  number = {4},
  pages = {5--13},
  doi = {10.1002/jhrm.70021}
}
Kostenlos starten →